The latest updates on our research and how it is improving people’s lives.
Oxford researchers awarded funding to study the immune response to malaria
15 March 2022
Professors Matthew Higgins and Michael Dustin from the University of Oxford, Prof Gavin Wright from the University of York, and Professors Shiroh Iwanaga and Hisashi Arase from Osaka University have secured a Wellcome Collaborative Award for their study “How do RIFINs and STEVORs modulate human immunity during malaria?”
Oxford leads global cross-collaboration Covid research
14 March 2022
A new collaboration between Oxford, Brazil and Pakistan has been funded by the Bill & Melinda Gates Foundation. The partnership will provide researchers with de-identified health data from two of the worlds global COVID-19 hotspots to increase understanding of COVID-19 in these communities and help accelerate the management of the disease.
Study reveals that bone changes the energy requirements of cancer cells to promote growth and survival
11 March 2022
Interrogating metabolic crosstalk in the tumour-bone microenvironment, new research from the Edwards group shows how the pentose phosphate pathway contributes to prostate cancer bone metastasis.
Family raises money for Psoriatic Arthritis research in Oxford
10 March 2022
The family of Terry Barber visited the Botnar Institute for Musculoskeletal Sciences today to present a cheque for £350 in his memory.
Funding boost for early-stage clinical research
8 March 2022
Oxford is one of 28 sites that will benefit from over £160 million awarded over five years to expand early phase clinical research for the benefit of NHS patients.
New funding awarded to study persistent pain in inflammatory arthritis
7 March 2022
The £3.9M Wellcome Collaborative Award will be used to identify the drivers of pain in people living with rheumatoid arthritis.
Two new initiatives launched to support staff and student wellbeing
23 February 2022
People are at the heart of NDORMS and as such the department is dedicated to fostering an inclusive and supportive culture for all its staff and students. Two new initiatives have been recently launched; the mediation service, and a mental health first aiders programme.
Professor Jonathan Rees appointed as new Head of Department at NDORMS
14 February 2022
Prof Jonathan Rees will take up the leadership role on 1 April.
NDORMS joins DARWIN EU® Coordination Centre for drug and vaccine safety
11 February 2022
The European Medicines Agency has announced the establishment of the Data Analysis and Real World Interrogation Network (DARWIN EU®) to support better decision making on the development and effectiveness of medicines and vaccines.
Cemented hip replacement improves quality of life for patients over 60
10 February 2022
The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.
Kassim Javaid awarded new funding for pioneering osteoporosis research
7 February 2022
Kassim Javaid has been announced as one the successful applicants of The Royal Osteoporosis Society’s largest ever research grants round.
NDORMS professors join Global Scholars Program
7 February 2022
Professors Stephanie Dakin and Paul Bowness have been announced as 2021 recipients of the Novartis Institutes for BioMedical Research (NIBR) Global Scholars Program (NGSP).
The Duchess of Cornwall opens the new Marcela Botnar wing
26 January 2022
A new building at the University of Oxford's Botnar Institute for Musculoskeletal Sciences has been opened by The Duchess of Cornwall.
Plaster cast or metal pins to treat a broken wrist? The results are in.
19 January 2022
An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.
Professor Chris Buckley has joined the Kennedy Institute as Director of Clinical Research
12 January 2022
Moving to the University of Oxford with the Arthritis Therapy Acceleration Programme (A-TAP) will help accelerate the discovery of new treatments for inflammatory diseases.
Behind enemy lines: research finds a new ally in the fight against cardiovascular disease hidden within the vessel wall itself
11 January 2022
A new study reveals the existence of a powerful ally in the fight against cardiovascular disease, a protective subset of vascular macrophages expressing the C-type lectin receptor CLEC4A2, a molecule which fosters “good” macrophage behaviour within the vessel wall.
More effective treatment found for patients hospitalised with COVID-19 pneumonia
20 December 2021
A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.
NDORMS researchers honoured in the Recognition Of Distinction Scheme 2021
17 December 2021
Sally Hopewell and John Christianson have been awarded the title of ‘Full Professor’ in the University of Oxford’s Recognition Of Distinction Scheme 2021.
New Oxford-Zeiss Centre of Excellence opens at the University of Oxford
17 December 2021
The Kennedy Institute for Rheumatology and the Institute of Developmental and Regenerative Medicine announce the launch of the Oxford-Zeiss Centre of Excellence, providing state-of-the-art imaging technologies to lead future discoveries in global health and disease.
HOPE-c opens up for recruitment
15 December 2021
Researchers in the Centre for OA Pathogenesis Versus Arthritis at the Kennedy Institute of Rheumatology and Imperial College London are looking to recruit adults with painful hand osteoarthritis for an observational study to help uncover why people living with the condition experience different patterns of pain.